Impact of Protect Your Colon™ on CRC Screening
ConditionColorectal Cancer Screening
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorCedars-Sinai Medical Center
About this trial
The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.
Eligibility criteria
Qualifiers
Individuals 45 to 75 years old
No prior CRC screening or not up-to-date with CRC screening
Not at high risk for CRC (e.g., inflammatory bowel disease, colon polyposis syndromes, family history of CRC)
No prior colon polyps
Disqualifiers
Does not speak English
Does not have internet access
Any records flagged "break the glass" or "research opt out."
Trial design
Treatments tested in this trial
- Protect Your Colon™
Treatment groups
184 Participants
are divided into 2 treatment groupsSponsors and collaborators
Cedars-Sinai Medical Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov